NEM vs. RIGL

Last updated Jun 13, 2026

NEM (Newmont Corporation) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. NEM operates in Gold (Basic Materials), while RIGL operates in Biotechnology (Healthcare). Over the past 10 years, NEM returned 13.80%/yr vs 3.28%/yr for RIGL. At a 0.09 correlation, their price movements are largely independent.

Performance

NEM vs. RIGL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Newmont Corporation (NEM) and Rigel Pharmaceuticals, Inc. (RIGL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NEM achieves a 0.82% return, which is significantly higher than RIGL's -23.30% return. Over the past 10 years, NEM has outperformed RIGL with an annualized return of 13.80%, while RIGL has yielded a comparatively lower 3.28% annualized return.

NEM

• 1D: 2.71%
• 1M: -15.55%
• YTD: 0.82%
• 6M: 2.58%
• 1Y: 81.14%
• 3Y*: 36.14%
• 5Y*: 10.51%
• 10Y*: 13.80%

RIGL

• 1D: 2.40%
• 1M: 2.24%
• YTD: -23.30%
• 6M: -19.45%
• 1Y: 54.23%
• 3Y*: 27.10%
• 5Y*: -3.96%
• 10Y*: 3.28%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NEM vs. RIGL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NEM Newmont Corporation	0.82%	172.82%	-7.83%	-8.76%	-20.77%	7.40%	40.28%	30.52%	-6.15%	10.91%
RIGL Rigel Pharmaceuticals, Inc.	-23.30%	154.64%	16.00%	-3.33%	-43.40%	-24.29%	63.55%	-6.96%	-40.72%	63.03%

Correlation

The correlation between NEM and RIGL is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.13
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.09
Correlation (10Y) Calculated over the trailing 10-year period	0.08
Correlation (All Time) Calculated using the full available price history since Nov 29, 2000	0.09

Fundamentals

EPS NEM : $6.34 RIGL : $19.21
PE Ratio NEM : 15.82 RIGL : 1.71
PEG Ratio NEM : 0.41 RIGL : 0.00
PS Ratio NEM : 4.83 RIGL : 2.08
Total Revenue (TTM) NEM : $17.23B RIGL : $299.77M
Gross Profit (TTM) NEM : $8.97B RIGL : $279.95M
EBITDA (TTM) NEM : $13.78B RIGL : $125.80M

Return for Risk

NEM vs. RIGL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NEM

NEM Risk / Return Rank: 82
NEM Sharpe Ratio Rank: 86
NEM Sortino Ratio Rank: 78
NEM Omega Ratio Rank: 80
NEM Calmar Ratio Rank: 82
NEM Martin Ratio Rank: 84

RIGL

RIGL Risk / Return Rank: 67
RIGL Sharpe Ratio Rank: 68
RIGL Sortino Ratio Rank: 70
RIGL Omega Ratio Rank: 69
RIGL Calmar Ratio Rank: 65
RIGL Martin Ratio Rank: 61

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NEM vs. RIGL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Newmont Corporation (NEM) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	NEM	RIGL	Difference
Sharpe ratio: Return per unit of total volatility	1.73	0.78	+0.95
Sortino ratio: Return per unit of downside risk	2.08	1.64	+0.43
Omega ratio: Gain probability vs. loss probability	1.29	1.20	+0.09
Calmar ratio: Return relative to maximum drawdown	2.78	1.09	+1.69
Martin ratio: Return relative to average drawdown	7.58	1.91	+5.68

NEM vs. RIGL - Sharpe Ratio Comparison

The current NEM Sharpe Ratio is 1.73, which is higher than the RIGL Sharpe Ratio of 0.78. The chart below compares the historical Sharpe Ratios of NEM and RIGL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

NEM vs. RIGL - Drawdown Comparison

The maximum NEM drawdown since its inception was -81.30%, smaller than the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for NEM and RIGL.

Drawdown Indicators

	NEM	RIGL	Difference
Max Drawdown Largest peak-to-trough decline	-81.30%	-99.37%	+18.07%
Max Drawdown (1Y) Largest decline over 1 year	-29.39%	-50.08%	+20.69%
Max Drawdown (3Y) Largest decline over 3 years	-36.57%	-57.75%	+21.18%
Max Drawdown (5Y) Largest decline over 5 years	-62.40%	-85.24%	+22.84%
Max Drawdown (10Y) Largest decline over 10 years	-62.40%	-86.40%	+24.00%
Current Drawdown Current decline from peak	-23.71%	-96.93%	+73.22%
Average Drawdown Average peak-to-trough decline	-41.37%	-90.91%	+49.54%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.73%	28.64%	-17.91%

Volatility

NEM vs. RIGL - Volatility Comparison

Newmont Corporation (NEM) has a higher volatility of 15.74% compared to Rigel Pharmaceuticals, Inc. (RIGL) at 12.05%. This indicates that NEM's price experiences larger fluctuations and is considered to be riskier than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NEM	RIGL	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.74%	12.05%	+3.69%
Volatility (6M) Calculated over the trailing 6-month period	37.43%	36.64%	+0.79%
Volatility (1Y) Calculated over the trailing 1-year period	47.44%	69.89%	-22.45%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	37.99%	85.46%	-47.47%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	35.67%	82.81%	-47.14%

Dividends

NEM vs. RIGL - Dividend Comparison

NEM's dividend yield for the trailing twelve months is around 1.02%, while RIGL has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NEM Newmont Corporation	1.02%	1.00%	2.69%	3.87%	4.66%	3.55%	1.74%	3.31%	1.62%	0.67%	0.37%	0.56%
RIGL Rigel Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both NEM and RIGL in my portfolio?

NEM and RIGL have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NEM or RIGL?

NEM has higher volatility (15.74%) compared to RIGL (12.05%). In terms of maximum drawdown, NEM dropped -81.30% vs RIGL's -99.37%.

Which has better risk-adjusted returns?

NEM currently has the higher Sharpe Ratio (1.73 vs 0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.